HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 385631Erstellt: 26. Oktober 2026
Sodium Chloride → 7-chloro-6-(((1-(2-(2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-yl)amino)methyl)-2H-pyrido(3,2-b)(1,4)thiazin-3(4H)-one hydrochloride
https://huagongshe.com/reaction/385631
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Sodium Chloride | HCID 5234 | — |
| Edukt | Sodium Bicarbonate | HCID 516892 | — |
| Edukt | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Edukt | 7-Chloro-3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde | HCID 21873589 | — |
| Edukt | 1-(2-(4-aminopiperidin-1-yl)ethyl)-1,8-naphthyridin-2(1H)-one | HCID 57815259 | — |
| Lösungsmittel | Acetic Acid | HCID 176 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Lösungsmittel | Chloroform | HCID 6212 | — |
| Lösungsmittel | Dichloromethane | HCID 6344 | — |
| Produkt | 7-chloro-6-(((1-(2-(2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-yl)amino)methyl)-2H-pyrido(3,2-b)(1,4)thiazin-3(4H)-one hydrochloride | HCID 24866872 | 109,2% |
Reaktionsschritte
To a solution of 0.07 g of 1-(2-(4-aminopiperidin-1-yl)ethyl)-1,8-naphthyridin-2(1H)-one in 3 mL of dichloromethane, 57 mg of 7-chloro-3-oxo-3,4-dihydro-2H-pyrido(3,2-b)(1,4)thiazine-6-carbaldehyde and 14 μL of acetic acid were added, the mixture was stirred for 10 minutes, and then, 79 mg of sodium triacetoxyborohydride was added to the reaction mixture, and the mixture was reacted for 1 day. Thereto was further added 7 μL of acetic acid, the mixture was stirred for 35 minutes, and then, 7 μL of acetic acid and 26 mg of sodium triacetoxyborohydride was added thereto, and the mixture was reacted for 20 minutes. To the reaction mixture, water, a saturated aqueous sodium hydrogen carbonate solution, chloroform and sodium chloride were added, the organic layer was separated, and the aqueous layer was extracted with chloroform while salting out. The organic layer and the extract were combined, the resultant solution was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The resultant residue was dissolved in 5 mL of 6 mol/L hydrochloric acid, and the solvent was distilled off under reduced pressure. The resultant residue was purified by reverse silica gel column chromatography using an eluent of water to obtain 71 mg of 7-chloro-6-(((1-(2-(2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-yl)amino)methyl)-2H-pyrido(3,2-b)(1,4)thiazin-3(4H)-one hydrochloride as a light gray solid.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US08367831B2 |
|---|
| Quelldatensatz | uspto-grants-2013_02 |
|---|
| ORD ID | ord-29f2acafca874fd2bc5011a049f6097a |
|---|
| Quellennotiz | uspto-grants-2013_02 |
|---|